Triglyceride Glucose-Body Mass Index Is a Simple and Clinically Useful Surrogate Marker for Insulin Resistance in Nondiabetic Individuals.
Er LK, Wu S, Chou HH, Hsu LA, Teng MS, Sun YC, Ko YL. · 2016
Read Triglyceride Glucose-Body Mass Index Is a Simple and Clinically Useful Surrogate Marker for Insulin Resistance in Nondiabetic Individuals. by Er LK, Wu S, Chou HH, Hsu LA, Teng MS, Sun YC, Ko YL. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4773118.txt.
Introduction
Leay-Kiaw Er leads eight authors in PLoS ONE in 2016 testing a simple index for insulin resistance. When the body stops answering insulin well, diabetes and heart disease follow, yet the lab tests that prove resistance are too involved for routine screening. The team compared many cheap blood and body measures to find one that flags resistance early.
From 511 adults in Taiwan without diabetes, they scored fat and sugar measures against a standard resistance index. A combined score, blood fats times fasting sugar times body mass index, tracked resistance strongly and sorted people well. A hormone ratio did as well but costs more to run. The authors present the combined score as a clinic-ready screen built from three routine numbers.
Catalog record
| CREATOR | Er LK, Wu S, Chou HH, Hsu LA, Teng MS, Sun YC, Ko YL. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Triglyceride Glucose-Body Mass Index Is a Simple and Clinically Useful Surrogate Marker for Insulin Resistance in Nondiabetic Individuals By Leay-Kiaw Er, Semon Wu, Hsin-Hua Chou, Lung-An Hsu, Ming-Sheng Teng, Yu-Chen Sun, Yu-Lin Ko, Marta Letizia Hribal Published in: PLoS ONE DOI: 10.1371/journal.pone.0149731 ABSTRACT Abstract Background Insulin resistance (IR) and the consequences of compensatory hyperinsulinemia are pathogenic factors for a set of metabolic abnormalities, which contribute to the development of diabetes mellitus and cardiovascular diseases. We compared traditional lipid levels and ratios and combined them with fasting plasma glucose (FPG) levels or adiposity status for determining their efficiency as independent risk factors for IR. Methods We enrolled 511 Taiwanese individuals for the analysis. The clinical usefulness of various parameters—such as traditional lipid levels and ratios; visceral adiposity indicators, visceral adiposity index (VAI), and lipid accumulation product (LAP); the product of triglyceride (TG) and FPG (the TyG index); TyG with adiposity status (TyG-body mass index [BMI]) and TyG-waist circumference index [WC]); and adipokine levels and ratios—was analyzed to identify IR. Results For all lipid ratios, the TG/high-density lipoprotein cholesterol (HDL-C) ratio had the highest additional percentage of variation in the homeostasis model assessment of insulin resistance (HOMA-IR; 7.0% in total); for all variables of interest, TyG-BMI and leptin-adiponectin ratio (LAR) were strongly associated with HOMA-IR, with 16.6% and 23.2% of variability, respectively. A logistic regression analysis revealed similar patterns. A receiver operating characteristic (ROC) curve analysis indicated that TG/HDL-C was a more efficient IR discriminator than other lipid variables or ratios. The area under the ROC curve (AUC) for VAI (0.734) and TyG (0.708) was larger than that for TG/HDL-C (0.707). TyG-BMI and LAR had the largest AUC (0.801 and 0.801, respectively). Conclusion TyG-BMI is a simple, powerful, and clinically useful surrogate marker for early identification of IR. INTRODUCTION Insulin resistance (IR) involves reduced muscle and adipose tissue sensitivities to insulin and reduced ability of the liver to suppress hepatic glucose production and output [1]. IR is considered a major risk factor for type 2 diabetes and cardiovascular (CV) diseases [2]. Because of the clinical importance of IR, the ability to identify individuals with IR before the development of cardiometabolic diseases is of paramount importance. Although the hyperinsulinemic euglycemia clamp remains the gold standard for measuring IR [3], its practical clinical application is limited by the labor intensiveness and cost and by ethical concerns. Therefore, a simple, reliable, and reproducible index for measuring IR is urgently required. It has been demonstrated that the product of TG and FPG levels (TyG index) presents moderate power as a surrogate marker for estimating HOMA-IR index in healthy subjects [4]. And The TyG index has high sensitivity and specificity compared with the euglycemic hyperinsulinemic clamp test for recognizing IR [5]. The superiority of the TyG index in identifying IR was also reported in many other studies [6,7,8]. With these findings, a highly efficient substitute measure to establish IR can be easily applied in clinical setting. Previous studies also proposed other new formulas for estimating IR from adiposity. The visceral adiposity index (VAI), a mathematical model used to identify IR, is based on the anthropometric body mass index (BMI), waist circumference (WC), and metabolic (TG and HDL-C) parameters [9,10]. The lipid accumulation product (LAP), another mathematical model calculated from the WC and fasting TG levels, has been demonstrated as an alternative index for lipid accumulation and as a surrogate marker for IR [11,12]. Recently, a cross-sectional study directly compared lipid ratios, VAI, LAP, and TyG for measuring their IR detection efficiency, and the TyG was revealed to be the most efficient marker for early identification of IR [6]. BMI and WC are simple, inexpensive and noninvasive anthropometric parameters and are commonly adopted as useful indicators of obesity and other metabolic risk. As evidence increasingly suggests that obesity exhibits a close relationship with IR and because TyG are well-established as promising surrogate marker of IR, a combination of obesity and TyG can potentially identify IR more strongly than other surrogate markers. Thus, in this investigation, we compare lipid, adipokines, and lipid and adipokine ratios, visceral adiposity indicators, TyG and TyG related parameters (TyG-WC, TyG BMI) for early identification of IR. We analyzed whether a combination of TyG with BMI or WC can be a more powerful, simple and inexpensive clinical surrogate marker for IR. SUBJECTS AND METHODS Study population This study was approved by the institutional review board of the Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (IRB number: 98-IRB-021-XD). Participants were recruited during cardiovascular health examinations between October 2003 and September 2005 at Chang Gung Memorial Hospital. All the study individuals provided written informed consent. Medical history- and lifestyle characteristics-related questionnaire responses were collected. Cancer; current renal or liver disease; and a history of myocardial infarction, stroke, or transient ischemic attacks were the exclusion criteria. An initial recruitment revealed 617 individuals. In addition, participants with diabetes mellitus (defined as fasting blood glucose≧7.0 mmol/L (7 individuals) or the regular use of medications for diabetes mellitus (11 individuals)), aged <18 years (5 individuals), triglyceride levels > 500 mg/dL (10 individuals) and a history of regular medication for hypertension (66 individuals) or hyperlipidemia (9 individuals) were excluded. Finally, we enrolled 511 people—257 men and 254 women—for the analysis. Blood pressure was measured with patients in the sitting position after a 15-min rest period. Weight was measured on a calibrated beam scale with participants wearing light clothing, and height was measured without shoes. BMI was calculated by dividing weight (in kilograms) by the square of height (in meters). WC was measured using an inelastic tape at the midpoint of the bottom of the rib cage and the top of the iliac crest. Fasting blood samples were obtained from each participant. Current smoker was defined as smoking at least 1 cigarette per day at the time of survey. Alcohol consumption was defined as anyone who consumed alcohol once a day or more. Exercise was defined as regular exercise one or more times per week, at least 20 min for each time. Table 1 summarizes the clinical and biometric features of the study group stratified by sex and IR. [Table: Baseline Characteristics of the Study Subjects.] Laboratory examinations and assays Lipid variables were performed according to the methods described by Teng et al. [13]. Non-HDL-C was calculated by subtracting high density lipoprotein cholesterol (HDL-C) from total cholesterol (TC). FPG was enzymatically determined by using the hexokinase method. Serum insulin levels were measured using an immunoradiometric assay (Bio-source, Nivelles, Belgium). Homeostasis model assessment of insulin resistance (HOMA-IR) was calculated using the following formula: HOMA-IR = fasting insulin (μU/mL) × FPG (mmol/L)/22.5 [14]. Insulin resistance was recognized when the HOMA-IR index reached the upper quartile. The C-reactive protein (CRP) level was measured by using a sandwich-type enzyme-linked immunosorbent assay (ELISA), which was developed in house. [15]. Serum leptin and adiponectin levels also were measured using an in-house sandwich-type ELISA assay. All in-house kits showed good correlation when compared with commercially available ELISA kits [15,16,17]. Circulating resistin levels were measured using commercially available ELISA kits (R&D Systems, Minneapolis, MN, USA). The within-day precision and day-to-day precision were 2.2% and 2.1% for TC, 3.4% and 4.5% for HDL-C, 2.3% and 3.0% for LDL-C, 2.0% and